Delivery Order SPE2DB20D1110-SPE2DB25FK04H
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $4,588.80 and is a firm fixed price delivery order that runs through June 4, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Ondansetron HCL 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $13,518.72 and a period of performance through May 1, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,320.80 and is for the delivery of Ondansetron HCL 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of November 27, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $2,097.07 and a performance period through June 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global...
This federal contract award from the Defense Logistics Agency (DLA) is a Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg Tablets. The contract has a ceiling value of $2,155.80 and a performance period through May 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $4,204.53 and is a firm fixed-price Delivery Order that runs through June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,865.48 firm fixed-price delivery order is for the supply of 4 mg ondansetron HCL tablets. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,183.30, is for the delivery of 4,567,670,855 units of Ondansetron HCL 4 mg tablets. It is a firm fixed-price delivery order contract that runs through March 25, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $30,124.03, is for the delivery of Ondansetron HCL 4 mg tablets in 30-count packaging. The contract has a performance period through January 17, 2025 and is a firm fixed-price delivery order. This contract award is not associated with a set-aside designation. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,115.84, is for the delivery of 4,567,770,527 units of ondansetron HCL 4 mg tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...